Complementary and alternative medications in the management of inflammatory bowel disease

Therapeutic Advances in Gastroenterology
Sherman PicardoCynthia H Seow

Abstract

The use of complementary and alternative medications (CAM), products, and therapies not considered to be part of conventional medicine is common among patients with inflammatory bowel disease (IBD). Patients often turn to these therapies as they are considered natural and safe, with significant benefit reported beyond disease control. There is emerging evidence that some of these therapies may have anti-inflammatory activity; however, robust evidence for their efficacy in modulating disease activity is currently lacking. Patients often avoid discussing the use of CAM with their physicians, which may lead to drug interactions and/or reduced adherence with conventional therapy. It is important for physicians to be aware of the commonly used CAM and current evidence behind these therapies in order to better counsel their patients about their use in the management of IBD. This narrative review provides an overview of the evidence of the more commonly used CAM in patients with IBD.

References

Jun 13, 1998·The American Journal of Gastroenterology·Y Z AlmallahO Eremin
Mar 15, 2002·The American Journal of Medicine·Heiner C BucherGabriela Meier
Dec 14, 2002·Journal of the American College of Nutrition·Artemis P Simopoulos
Jul 23, 2003·The American Journal of Gastroenterology·Robert J HilsdenGaia Pocobelli
Sep 26, 2003·The Proceedings of the Nutrition Society·Lucy M Browning
Mar 12, 2004·Journal of Ethnopharmacology·W SuvitayavatN Bunyapraphatsara
Mar 27, 2004·Alimentary Pharmacology & Therapeutics·L LangmeadD S Rampton
Jan 22, 2005·Annals of the New York Academy of Sciences·Hee-Gu LeeDo-Young Yoon
Apr 12, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Douglas L SeidnerStephen J Demichele
Jun 30, 2005·The American Journal of Gastroenterology·Rodrigo BibiloniR Balfour Sartor
Oct 4, 2005·Alimentary Pharmacology & Therapeutics·B ShenB A Lashner
Oct 22, 2005·Digestive Diseases and Sciences·Peter R HoltRobert Kirshoff
Feb 2, 2006·Planta medica·Valeria MoscatelliGraciela Ferraro
May 16, 2006·Alimentary Pharmacology & Therapeutics·M A ZoccoA Gasbarrini
Nov 15, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hiroyuki HanaiYukio Koide
Jan 24, 2007·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·B OmerT O Noor
Sep 29, 2007·Biochemical Pharmacology·Ajay GoelBharat B Aggarwal
Oct 16, 2007·Diseases of the Colon and Rectum·Paolo GionchettiMassimo Campieri
Nov 15, 2007·Molecular Pharmaceutics·Preetha AnandBharat B Aggarwal
Feb 23, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·A SethR K Rao
Apr 10, 2008·JAMA : the Journal of the American Medical Association·Brian G FeaganPaul Rutgeerts
Feb 18, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·Rudolf MennigenMatthias Bruewer
Jul 28, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ajit SoodRakesh K Tandon
Aug 8, 2009·Journal of the American College of Cardiology·Carl J LavieHector O Ventura
Dec 8, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Simone KrebsBilal Omer
Jun 1, 2010·The Proceedings of the Nutrition Society·Michael JamesLes Cleland
Sep 18, 2010·Inflammatory Bowel Diseases·Robert J HilsdenJennifer C C DeBruyn
Mar 4, 2011·Alimentary Pharmacology & Therapeutics·S Ben-Horin, Y Chowers
Apr 6, 2011·Gut·Craig MowatUNKNOWN IBD Section of the British Society of Gastroenterology

❮ Previous
Next ❯

Citations

Aug 11, 2020·Expert Review of Gastroenterology & Hepatology·Ricardo de Alvares GoulartElen Landgraf Guiguer
Jun 28, 2021·International Journal of Older People Nursing·Genevieve Z SteinerKate A McBride
Oct 2, 2021·Journal of Pediatric Gastroenterology and Nutrition·Maribeth R Nicholson, Stacy A Kahn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.